Research in my laboratory seeks to discover the cause of disease in children with rare and previously undiagnosed genetic problems with their blood cells (hematopoietic system), including platelets, red and white blood cells that often present as immune defects or cancer. This new understanding will provide us with novel insights into the normal function of the hematopoietic system and help us better understand what's wrong with cancer cells leading eventually to new therapies.
A Germline Mutation in the C2 Domain of PLC¿2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases
Journal of Clinical Immunology
Taylor Novice and Amina Kariminia and Kate L. Del Bel and Henry Lu and Mehul Sharma and Chinten J. Lim and Jay Read and Mark Vander Lugt and Mark C. Hannibal and David O’Dwyer and Mirie Hosler and Thomas Scharnitz and Jason M Rizzo and Jennifer Zacur and John Priatel and Sayeh Abdossamadi and Alexandra Bohm and Anne Junker and Stuart E. Turvey and Kirk R. Schultz and Jacob Rozmus
C-terminal truncation of IFN-¿ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease
Dufour, A. and Bellac, C.L. and Eckhard, U. and Solis, N. and Klein, T. and Kappelhoff, R. and Fortelny, N. and Jobin, P. and Rozmus, J. and Mark, J. and Pavlidis, P. and Dive, V. and Barbour, S.J. and Overall, C.M.
Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD
Bone Marrow Transplantation
Rozmus, J. and Ivison, S. and Kariminia, A. and Leung, V.M. and Sung, S. and Subrt, P. and Lee, S.J. and Boilard, E. and Walker, I. and Foley, R. and Lipton, J. and Gallagher, G. and Couban, S. and Schultz, K.R.
Y-box-binding protein 1 contributes to IL-7-Mediated survival signaling in B-cell precursor acute lymphoblastic leukemia
Kariminia, A. and Ivison, S.M. and Leung, V.M. and Sung, S. and Couto, N. and Rozmus, J. and Rolf, N. and Narendran, A. and Dunn, S.E. and Reid, G.S.D. and Schultz, K.R.
CD56brightnatural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: The Canadian blood and marrow transplant group randomized 0601 study results
Kariminia, A. and Ivison, S. and Ng, B. and Rozmus, J. and Sung, S. and Varshney, A. and Aljurf, M. and Lachance, S. and Walker, I. and Toze, C. and Lipton, J. and Lee, S.J. and Szer, J. and Doocey, R. and Lewis, I. and Smith, C. and Chaudhri, N. and Levings, M.K. and Broady, R. and Devins, G. and Szwajcer, D. and Foley, R. and Mostafavi, S. and Pavletic, S. and Wall, D.A. and Couban, S. and Panzarella, T. and Schultz, K.R.
XLF deficiency results in reduced N-nucleotide addition during V(D)J recombination.
IJspeert H and Rozmus J and Schwarz K and Warren RL and van Zessen D and Holt RA and Pico-Knijnenburg I and Simons E and Jerchel I and Wawer A and Lorenz M and Patiroglu T and Akar HH and Leite R and Verkaik NS and Stubbs AP and van Gent DC and van Dongen JJ and van der Burg M
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A and Holtan SG and Ivison S and Rozmus J and Hebert MJ and Martin PJ and Lee SJ and Wolff D and Subrt P and Abdossamadi S and Sung S and Storek J and Levings M and Aljurf M and Arora M and Cutler C and Gallagher G and Kuruvilla J and Lipton J and Nevill TJ
Exome Sequencing and the Management of Neurometabolic Disorders.
Tarailo-Graovac M and Shyr C and Ross CJ and Horvath GA and Salvarinova R and Ye XC and Zhang LH and Bhavsar AP and Lee JJ and Drögemöller BI and Abdelsayed M and Alfadhel M and Armstrong L and Baumgartner MR and Burda P and Connolly MB and Cameron J and Demos M and Dewan T and Dionne J
NANS-mediated synthesis of sialic acid is required for brain and skeletal development.
van Karnebeek CD and Bonafé L and Wen XY and Tarailo-Graovac M and Balzano S and Royer-Bertrand B and Ashikov A and Garavelli L and Mammi I and Turolla L and Breen C and Donnai D and Cormier V and Heron D and Nishimura G and Uchikawa S and Campos-Xavier B and Rossi A and Hennet T and Brand-Arzamendi K
Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation.
Rozmus J and McDonald R and Fung SY and Del Bel KL and Roden J and Senger C and Schultz KR and McKinnon ML and Davis J and Turvey SE
Successful umbilical cord blood hematopoietic stem cell transplantation in pediatric patients with MDS/AML associated with underlying GATA2 mutations: two case reports and review of literature
Mallhi, K. and Dix, D.B. and Niederhoffer, K.Y. and Armstrong, L. and Rozmus, J.
Functional hyposplenism after hematopoietic stem cell transplantation.
Rozmus J and Mallhi K and Ke J and Schultz KR
The genotypic and phenotypic spectrum of PIGA deficiency.
Tarailo-Graovac M and Sinclair G and Stockler-Ipsiroglu S and Van Allen M and Rozmus J and Shyr C and Biancheri R and Oh T and Sayson B and Lafek M and Ross CJ and Robinson WP and Wasserman WW and Rossi A and van Karnebeek CD
The CARD11-BCL10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE and Durandy A and Fischer A and Fung SY and Geha RS and Gewies A and Giese T and Greil J and Keller B and McKinnon ML and Neven B and Rozmus J and Ruland J and Snow AL and Stepensky P and Warnatz K
Combined immunodeficiency associated with homozygous MALT1 mutations.
McKinnon ML and Rozmus J and Fung SY and Hirschfeld AF and Del Bel KL and Thomas L and Marr N and Martin SD and Marwaha AK and Priatel JJ and Tan R and Senger C and Tsang A and Prendiville J and Junker AK and Seear M and Schultz KR and Sly LM and Holt RA and Patel MS
Primary Immune Deficiency Treatment Consortium (PIDTC) report.
Griffith LM and Cowan MJ and Notarangelo LD and Kohn DB and Puck JM and Pai SY and Ballard B and Bauer SC and Bleesing JJ and Boyle M and Brower A and Buckley RH and van der Burg M and Burroughs LM and Candotti F and Cant AJ and Chatila T and Cunningham-Rundles C and Dinauer MC and Dvorak CC
Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study.
Rozmus J and Junker A and Thibodeau ML and Grenier D and Turvey SE and Yacoub W and Embree J and Haddad E and Langley JM and Ramsingh RM and Singh VA and Long R and Schultz KR
Multiple persistent ganglioneuromas likely arising from the spontaneous maturation of metastatic neuroblastoma.
Rozmus J and Langer M and Murphy JJ and Dix D
Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.
Rozmus J and Schultz KR and Wynne K and Kariminia A and Satyanarayana P and Krailo M and Grupp SA and Gilman AL and Goldman FD
Biomarkers in chronic graft-versus-host disease.
Rozmus J and Schultz KR
3-year results of a collaborative school-based oral health program in a remote First Nations community.
Macnab AJ and Rozmus J and Benton D and Gagnon FA
Diabetes screening of children in a remote First Nations community on the west coast of Canada: challenges and solutions.
Rural and remote health
Panagiotopoulos, C. and Rozmus, J. and Gagnon, R.E. and Macnab, A.J.
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.
Braun BS and Tuveson DA and Kong N and Le DT and Kogan SC and Rozmus J and Le Beau MM and Jacks TE and Shannon KM
Herpes simplex virus triggers and then disarms a host antiviral response.
Mossman KL and Macgregor PF and Rozmus JJ and Goryachev AB and Edwards AM and Smiley JR
Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
Janowska-Wieczorek A and Marquez LA and Nabholtz JM and Cabuhat ML and Montaño J and Chang H and Rozmus J and Russell JA and Edwards DR and Turner AR
3. Determining the mechanism of A-kinase anchor protein (AKAPs) dysfunction in undiagnosed familial thrombocytopenia syndromes
2. Understanding the molecular cause and pathophysiology of systemic capillary leak syndrome in children
The role of sumoylation in immune cell function: Sumoylation is a post-translational modification involving the addition of SUMO (small ubiquitin-like modifiers) groups that regulate protein function. This modification plays an important role in a wide range of cellular processes including protein stability, nuclear-cytosolic transport, apoptosis and cell cycle progression. We have identifed a number of rare disease patients with defects in sumoylation pathways that present with abnormal immune cell function, defective hematopoiesis and blood cancers. Studying their defects has provided novel insights into how sumoylation regulates immunity and hematopoiesis.Honours & Awards
Best Oral Abstract Presentation Award, CBMTG 2016 Annual Conference, Vancouver, Canada; 2016
Canadian Child Health Clinician Scientist Program (CCHCSP) Predoctoral Award, 2012
Vanier Canada Graduate Scholarship, 2012
Primary Immune Deficiency Transplant Consortium (PIDTC) Fellowship Award, 2011
Senior Resident Award for Excellence in Pediatrics, Dept. of Pediatrics, BC Children's Hospital 2007-2008
Participant in the Clinical Immunology Society's (CIS) School in Primary Immunodeficiency Diseases, September 2010
Reach for the Top Prize for best abstract at 85th Canadian Pediatric Society annual conference (Victoria, BC), 2008
CIHR Fellowship (Health Professional), 2012
Award of Distinction, Family Centred Care Awards from Partners in Care Family Advisory at BC Children's Hospital, 2008
Award of Excellence for Contribution to the Diabetic Screening Project in BC First Nations Children, June 2008
American Pediatric Society and Society for Pediatric Research Studentship at University of California, San Francisco (Hematopoietic Progenitor Cell Research), 2003
UBC Four Year Fellowship Graduate Award, 2010
UBC Clinician Investigator Program Research Day, Best Poster Presentation Award, 2012
UBC Faculty of Medicine Graduate Award, 2010Research Group Members
Verena Goebeler, Research Assistant
Maia Poon, BCCHRI Summer Student
Brenda Tse, Research Coordinator
Study finds new biomarker for a disease caused by bone marrow transplant
A new study led by investigators at BC Children's Hospital has discovered a metabolic marker for chronic graft versus host disease.